Clinical trials: Hypnotic; Sleep Disorder
Chronic Insomnia, Chronic Pain
Lemborexant vs Clonidine vs Sedatives to Treat Insomnia in Chronic Pain Patients
Prospective observational crossover study of 250 adults undergoing chronic pain management. For insomnia treatment, patients alternate their usual prescribed sedative versus Lemborexant or Clonidine; on alternate nights.
- Conditions
- Chronic Insomnia, Chronic Pain, Restless Leg Syndrome (RLS), Substance Abuse
- Trial name
- NCT05618002
- Testing
- Lemborexant
- Where
- Canada
- Volunteers
- 250 people
- Sponsor
- Salem Anaesthesia Pain Clinic
Obstructive Sleep Apnea
Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?
This study is being conducted to determine if eszopiclone is as effective as ramelteon when used as a pre-medication (sleeping pill) in sleep studies performed to diagnose and treat sleep apnea.
- Trial name
- NCT00811746
- Testing
- Rozerem (Ramelteon), Lunesta (Eszopiclone), Historical Controls
- Where
- United States
- Volunteers
- 90 people
- Sponsor
- Southern California Institute for Research and Education
Sleep Initiation and Maintenance Disorders, Depression
Improving Sleep and Psychological Functioning in People With Depression and Insomnia
This study will evaluate the safety and effectiveness of treatment with both a sleeping pill and antidepressant medication in improving sleep and psychological functioning in people with depression and insomnia.
- Trial name
- NCT00247624
- Testing
- Eszopiclone, Fluoxetine
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Wake Forest University Health Sciences
Hypnotic; Sleep Disorder
A Self-help Book for Insomnia Compared With Sleep Hygiene Advice in Patients Using Sleep Medications
The aim is to assess whether a self-help book for insomnia will improve sleep and reduce hypnotic use among patients on sleep medications.
- Trial name
- NCT05069285
- Testing
- self-help book, sleep hygiene advice
- Where
- Norway
- Volunteers
- 172 people, healthy volunteers welcome
- Sponsor
- University of Bergen
Insomnia Chronic, Pain, Chronic
Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients
A prospective observational crossover study of 160 consenting adult patients who underwent pain management. For insomnia treatment, each patient ingested different prescribed doses of Zopiclone or Clonidine on alternate nights.
- Trial name
- NCT05277038
- Testing
- Clonidine 0.1mg pill, Clonidine 0.2mg pill, Zopiclone 3.75mg pill
- Where
- Canada
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Salem Anaesthesia Pain Clinic
Benzodiazepines Deprescribing, Sleep Problems
Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.
Among older adults (≥65 years), use of sleeping pills, such as benzodiazepines and other sedative-hypnotics, to treat sleep problems is common.
- Trial name
- BE-SAFE (NCT06584513)
- Testing
- Specific tapering plan for sleep medication, educational and cognitive behavioural therapy elements
- Where
- 6 sites in Belgium, Greece and 4 more
- Volunteers
- 470 people
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Sleep Initiation and Maintenance Disorders
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.
- Trial name
- NCT00401284
- Testing
- EVT 201
- Where
- 22 sites in United States
- Volunteers
- 135 people
- Sponsor
- Evotec Neurosciences GmbH
Primary Insomnia
Safety and Efficacy of Chronic Hypnotic Use
The purpose of the study is to determine how safe and effective it is for people with insomnia to use zolpidem on a nightly basis for one year.
- Trial name
- NCT01006525
- Testing
- zolpidem
- Where
- United States
- Volunteers
- 116 people, healthy volunteers welcome
- Sponsor
- Henry Ford Health System
Primary Insomnia
Study of the Insomnia in Patients With Low Back Pain
The purpose of this study is to examine whether insomnia due to chronic low back pain can improve with use of eszopiclone.
- Trial name
- NCT00365976
- Testing
- Eszopiclone
- Where
- United States
- Volunteers
- 58 people
- Sponsor
- Duke University
Sleep Disorders
Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
The aims of this study are to (1) examine the medication use patterns of commonly prescribed hypnotics and the factors that were associated with the long-term and short-term use patterns among the elderly population in Taiwan…
- Trial name
- RABA-HASDE (NCT02648776)
- Testing
- Exposure to sedative-hypnotic drugs
- Where
- Taiwan
- Volunteers
- 1,400 people, healthy volunteers welcome
- Sponsor
- China Medical University Hospital
Obstructive Sleep Apnea
Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)
The purpose of this study is to assess the efficacy of Eszopiclone in improving short and intermediate-term compliance with continuous positive airway pressure (CPAP) in patients newly diagnosed with obstructive sleep apnea (OSA).
- Trial name
- CPAPASAP (NCT00612157)
- Testing
- Eszopiclone
- Where
- United States
- Volunteers
- 154 people
- Sponsor
- Walter Reed Army Medical Center
Sleep Initiation and Maintenance Disorders
Sleep Without Insomnia or The Use of Chronic Hypnotics
Sleeping medications, called hypnotics, are often prescribed for insomnia and are associated with adverse health outcomes in older adults.
- Trial name
- SWITCH (NCT03687086)
- Testing
- Program A, Program B
- Where
- 2 sites in United States
- Volunteers
- 188 people
- Sponsor
- University of California, Los Angeles
Sleep Initiation and Maintenance Disorders
Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia
The primary objective is to evaluate the hypnotic efficacy of zolpidem-MR (modified release) 12.5 mg and zolpidem 10 mg marketed product in comparison with placebo in patients with primary insomnia and sleep maintenance…
- Trial name
- NCT00630175
- Testing
- zolpidem-MR (modified release), zolpidem (SL800750)
- Where
- 3 sites in United States, Australia and 1 more
- Volunteers
- 113 people
- Sponsor
- Sanofi
Sleep Disturbance, Insomnia
The Use of Amber Glasses in Improving Sleep
The use of amber glasses will aid the patient to fall asleep without the need for the use of hypnotic medication.
- Trial name
- NCT04751019
- Testing
- Amber Glasses
- Where
- United Kingdom
- Volunteers
- 15 people
- Sponsor
- Surrey and Borders Partnership NHS Foundation Trust
Aging, Balance
Sleepiness and the Risk of Falling
The purpose of this project is to examine the impact of sleeping pills and waking up in the middle of the night on walking balance and cognitive function, to identify risk factors for falls in older adults.
- Conditions
- Aging, Balance, Sleep
- Trial name
- NCT00383357
- Testing
- zolpidem
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- National Institute on Aging (NIA)
Insomnia, Hypnotic Dependence
Enhancing Hypnotic Medication Discontinuation in Primary Care
Many individuals with insomnia seek treatment in primary care settings, where they often receive prescription hypnotic medications as their first and sometimes only treatment.
- Trial name
- NCT06435520
- Testing
- Digital Cognitive Behavioral Therapy, Structured Medication Tapering
- Where
- United States
- Volunteers
- 430 people
- Sponsor
- National Jewish Health
Insomnia
Discontinuation of Hypnotics in Older Veterans
Sleeping medications, called hypnotics, are often prescribed for insomnia. About one-quarter of Veterans use hypnotics (or bedtime alcohol).
- Trial name
- SWITCH (NCT03511209)
- Testing
- CBTI plus taper method A, CBTI plus taper method B
- Where
- United States
- Volunteers
- 132 people
- Sponsor
- VA Office of Research and Development
Sleep Disorders
Optimization of Melatonin Administration in Healthy Adults
The goal of this clinical trial is to evaluate whether the timing and dosage of exogenous melatonin can improve sleep onset and maintenance in healthy adults aged 18-45 years (50% female) with no history of sleep disorders.
- Trial name
- MelOpt (NCT07514507)
- Testing
- Mel 2 mg 30 min, Mel 2 mg 3 h, Mel 4 mg 30 min
- Where
- Italy
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- IRCCS Fondazione Stella Maris
Insomnia, Primary Insomnia
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief.
- Conditions
- Insomnia, Primary Insomnia, Psychophysiologic Insomnia
- Trial name
- NCT00156533
- Testing
- Zolpidem, Sugar Pill
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Rochester
Obstructive Sleep Apnea
Ezopiclone Improves the Quality of Overnight Polysomnography
Patients often have difficulty sleeping during overnight sleep testing in a lab environment. The purpose of this study is to determine if taking a sleep aid will improve sleep and therefore the quality of the sleep study.
- Trial name
- NCT00507117
- Testing
- Lunesta
- Where
- United States
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Walter Reed Army Medical Center